找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lung Cancer and Personalized Medicine; Current Knowledge an Aamir Ahmad,Shirish Gadgeel Book 2016 The Editor(s) (if applicable) and The Aut

[復制鏈接]
樓主: 導彈
31#
發(fā)表于 2025-3-26 22:38:25 | 只看該作者
32#
發(fā)表于 2025-3-27 02:04:18 | 只看該作者
Bernhard Biersack,Rainer Schobert emission band. Instead, crests and crevices, rifts and ridges showed up in the recorded spectra. Soon these observed features were traced to either very weak absorption of matter or spurious interference inside the laser resonator [1]. This interpretation suggested that this ultra-sensitive respons
33#
發(fā)表于 2025-3-27 09:08:48 | 只看該作者
34#
發(fā)表于 2025-3-27 11:07:34 | 只看該作者
35#
發(fā)表于 2025-3-27 13:39:28 | 只看該作者
36#
發(fā)表于 2025-3-27 20:52:55 | 只看該作者
37#
發(fā)表于 2025-3-28 00:02:07 | 只看該作者
Immune Therapy,as shown that anti-tumor immune responses can occur in lung cancer patients, paving the way for lung cancer as a novel target for immunotherapy. In order to take full advantage of the potential of immunotherapy, research is focusing on the presence and function of various immunological cell types in
38#
發(fā)表于 2025-3-28 02:28:28 | 只看該作者
39#
發(fā)表于 2025-3-28 09:10:08 | 只看該作者
Target Therapy in Lung Cancer, Health Organization (WHO) typing system [1]. Because these variants have differing genetic and biological properties correct classification of lung cancer is necessary to assure that lung cancer patients receive optimum management. Due to the recent understanding that histologic typing and . mutati
40#
發(fā)表于 2025-3-28 11:30:41 | 只看該作者
Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update, mechanisms namely secondary mutation T790M in EGFR and cMET amplification. Other molecular mediators which contribute towards TKI resistance include the activation of compensatory growth signaling, epithelial mesenchymal transition and microRNAs regulating EGFR and cMET levels. In this chapter, we
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 11:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
巴青县| 丰台区| 泉州市| 吴桥县| 西吉县| 大渡口区| 壶关县| 鄱阳县| 永安市| 桃园市| 宜丰县| 连平县| 泰宁县| 抚宁县| 新化县| 长海县| 阳曲县| 凌源市| 庄河市| 康平县| 都昌县| 双牌县| 瓮安县| 墨竹工卡县| 和林格尔县| 色达县| 开远市| 吉林市| 永宁县| 星子县| 涪陵区| 白城市| 靖江市| 舟曲县| 五台县| 平安县| 页游| 安化县| 图们市| 汉源县| 喜德县|